On CAR-T’s Edge, Seattle Researchers Plot to Bypass Novartis Therapy – Xconomy
Xconomy |
On CAR–T's Edge, Seattle Researchers Plot to Bypass Novartis Therapy
Xconomy It's not a stretch to say that Greta Oberhofer is alive thanks to the genetically modified cell therapy called CAR–T. At three and a half months old, she was diagnosed with acute lymphoblastic leukemia, or ALL, an aggressive blood cancer. At 10 months … |
